Platelet-activating antibodies cause a hypercoagulable state and simultaneous reduction in platelet count.
	
- Sodium-channel blockers: quinine, class I antiarrhythmics (e.g., quinidine), valproate, carbamazepine
- Calcium-channel blockers: amlodipine
- Antibiotics: linezolid, vancomycin, TMP-SMX, penicillin, ceftriaxone, rifampin
- Antiviral agents: ganciclovir, protease inhibitors (e.g., indinavir), zidovudine
- Antithrombotic agents: glycoprotein IIb/IIIa inhibitors (e.g., abciximab), heparin
- Others: oxaliplatin, suramin, ibuprofen, mirtazapine
